Last reviewed · How we verify
Xcell Amnio Matrix — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Xcell Amnio Matrix (Xcell Amnio Matrix) — New Horizon Medical Solutions.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Xcell Amnio Matrix TARGET | Xcell Amnio Matrix | New Horizon Medical Solutions | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Xcell Amnio Matrix CI watch — RSS
- Xcell Amnio Matrix CI watch — Atom
- Xcell Amnio Matrix CI watch — JSON
- Xcell Amnio Matrix alone — RSS
Cite this brief
Drug Landscape (2026). Xcell Amnio Matrix — Competitive Intelligence Brief. https://druglandscape.com/ci/xcell-amnio-matrix. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab